Brain endothelial barrier passage by monocytes is controlled by the endothelin system

Journal of Neurochemistry

Volumn 121, Issue 5, 2012, Pages 730-737

  Reijerkerk, Arie ^a   Lakeman, Kim A M ^a   Drexhage, Joost A R ^a   Van Het Hof, Bert ^a   Van Wijck, Yolanda ^a   Van Der Pol, Susanne M A ^a   Kooij, Gijs ^a   Geerts, Dirk ^b   De Vries, Helga E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

blood brain barrier; diapedesis; endothelin; monocyte; neurological disease

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME;

ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; CELL CULTURE; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DIAPEDESIS; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MONOCYTE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ASPARTIC ACID ENDOPEPTIDASES; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; METALLOENDOPEPTIDASES; MONOCYTES; RECEPTORS, ENDOTHELIN; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84860509931     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07393.x     Document Type: Article

References (54)

1. Barone F. C., Willette R. N., Yue T. L., and, Feurestein G., (1995) Therapeutic effects of endothelin receptor antagonists in stroke. Neurol. Res. 17, 259-264.
2. Battistini B., Germain M., Fournier A., and, Sirois P., (1993) Structure-activity relationships of ET-1 and selected analogues in the isolated guinea pig trachea: evidence for the existence of different ETB receptor subtypes. J. Cardiovasc. Pharmacol. 22 (Suppl. 8), S219-S224. (Pubitemid 24027933)
3. Bendtsen J. D., Nielsen H., von Heijne G., and, Brunak S., (2004) Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340, 783-795. (Pubitemid 38829638)
4. Bkaily G., Avedanian L., Al-Khoury J., Provost C., Nader M., Orleans-Juste P., and, Jacques D., (2011) Nuclear membrane receptors for ET-1 in cardiovascular function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, 251-263.
5. Bruck W., Sommermeier N., Bergmann M., Zettl U., Goebel H. H., Kretzschmar H. A., and, Lassmann H., (1996) Macrophages in multiple sclerosis. Immunobiology 195, 588-600. (Pubitemid 26361485)
6. Chauhan A., Hahn S., Gartner S., Pardo C. A., Netesan S. K., McArthur J., and, Nath A., (2007) Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins. FASEB J. 21, 777-789. (Pubitemid 46348253)
7. Chen P., Shibata M., Zidovetzki R., Fisher M., Zlokovic B. V., and, Hofman F. M., (2001) Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J. Neuroimmunol. 116, 62-73. (Pubitemid 32322640)
8. Chen Q. W., Edvinsson L., and, Xu C. B., (2009) Role of ERK/MAPK in endothelin receptor signaling in human aortic smooth muscle cells. BMC. Cell Biol. 10, 52.
9. Dawson D. A., Sugano H., McCarron R. M., Hallenbeck J. M., and, Spatz M., (1999) Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia. Neurochem. Res. 24, 1499-1505.
10. Dehouck M. P., Vigne P., Torpier G., Breittmayer J. P., Cecchelli R., and, Frelin C., (1997) Endothelin-1 as a mediator of endothelial cell-pericyte interactions in bovine brain capillaries. J. Cereb. Blood Flow Metab. 17, 464-469. (Pubitemid 27188543)
11. Elkord E., Williams P. E., Kynaston H., and, Rowbottom A. W., (2005) Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology 114, 204-212. (Pubitemid 40208937)
12. Feuerstein G., Gu J. L., Ohlstein E. H., Barone F. C., and, Yue T. L., (1994) Peptidic endothelin-1 receptor antagonist, BQ-123, and neuroprotection. Peptides 15, 467-469. (Pubitemid 24223323)
13. Floris S., Blezer E. L., Schreibelt G., Dopp E., van der Pol S. M., Schadee-Eestermans I. L., Nicolay K., Dijkstra C. D., and, de Vries H. E., (2004) Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 127, 616-627. (Pubitemid 38295477)
14. Hagiwara H., Nagasawa T., Yamamoto T., Lodhi K. M., Ito T., Takemura N., and, Hirose S., (1993) Immunochemical characterization and localization of endothelin ETB receptor. Am. J. Physiol. 264, R777-R783. (Pubitemid 23123272)
15. Hartz A. M., Bauer B., Fricker G., and, Miller D. S., (2004) Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1. Mol. Pharmacol. 66, 387-394. (Pubitemid 39329237)
16. Haufschild T., Shaw S. G., Kesselring J., and, Flammer J., (2001) Increased endothelin-1 plasma levels in patients with multiple sclerosis. J. Neuroophthalmol. 21, 37-38. (Pubitemid 32217099)
17. Hembury A., and, Mabondzo A., (2008) Endothelin-1 reduces p-glycoprotein transport activity in an in vitro model of human adult blood-brain barrier. Cell. Mol. Neurobiol. 28, 915-921.
18. Huggins J. P., Pelton J. T., and, Miller R. C., (1993) The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmacol. Ther. 59, 55-123. (Pubitemid 23294750)
19. Hunter A. R., and, Turner A. J., (2006) Expression and localization of endothelin-converting enzyme-1 isoforms in human endothelial cells. Exp. Biol. Med. (Maywood.) 231, 718-722. (Pubitemid 43845516)
20. Jacques D., Descorbeth M., Abdel-Samad D., Provost C., Perreault C., and, Jules F., (2005) The distribution and density of ET-1 and its receptors are different in human right and left ventricular endocardial endothelial cells. Peptides 26, 1427-1435. (Pubitemid 41021477)
21. Jacques D., Sader S., Perreault C., Abdel-Samad D., Jules F., and, Provost C., (2006) NPY, ET-1, and Ang II nuclear receptors in human endocardial endothelial cells. Can. J. Physiol. Pharmacol. 84, 299-307. (Pubitemid 44481093)
22. Josko J., Hendryk S., Jedrzejowska-Szypulka H., Slowinski J., Gwozdz B., Lange D., and, Harabin-Slowinska M., (2000) Reactivity of cerebral arteries after subarachnoid hemorrhage in rats after phosphoramidon administered. Med. Sci. Monit. 6, 976-980.
23. Kallakuri S., Kreipke C. W., Schafer P. C., Schafer S. M., and, Rafols J. A., (2010) Brain cellular localization of endothelin receptors A and B in a rodent model of diffuse traumatic brain injury. Neuroscience 168, 820-830.
24. Kawai N., Yamamoto T., Yamamoto H., McCarron R. M., and, Spatz M., (1997) Functional characterization of endothelin receptors on cultured brain capillary endothelial cells of the rat. Neurochem. Int. 31, 597-605. (Pubitemid 27375870)
25. Khimji A. K., and, Rockey D. C., (2010) Endothelin - biology and disease. Cell. Signal. 22, 1615-1625.
26. Kobari M., Fukuuchi Y., Tomita M., Tanahashi N., Konno S., and, Takeda H., (1994) Dilatation of cerebral microvessels mediated by endothelin ETB receptor and nitric oxide in cats. Neurosci. Lett. 176, 157-160.
27. Kohno M., Yasunari K., Murakawa K., Yokokawa K., Horio T., Fukui T., and, Takeda T., (1990) Plasma immunoreactive endothelin in essential hypertension. Am. J. Med. 88, 614-618. (Pubitemid 20192275)
28. Kramer A., and, Fletcher J., (2009) Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis. Stroke 40, 3403-3406.
29. Lampl Y., Fleminger G., Gilad R., Galron R., Sarova-Pinhas I., and, Sokolovsky M., (1997) Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 28, 1951-1955. (Pubitemid 27459002)
30. Leung J. W., Chung S. S., and, Chung S. K., (2009) Endothelial endothelin-1 over-expression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion. Brain Res. 1266, 121-129.
31. Liu S., Premont R. T., Kontos C. D., Huang J., and, Rockey D. C., (2003) Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein betagamma subunit signaling to protein jinase B/Akt. J. Biol. Chem. 278, 49929-49935. (Pubitemid 37548828)
32. Masaoka H., Suzuki R., Hirata Y., Emori T., Marumo F., and, Hirakawa K., (1989) Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet 2, 1402. (Pubitemid 20003021)
33. Matsumura Y., Ikegawa R., Suzuki Y., Takaoka M., Uchida T., Kido H., Shinyama H., Hayashi K., Watanabe M., and, Morimoto S., (1991) Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci. 49, 841-848.
34. McCarron R. M., Wang L., Stanimirovic D. B., and, Spatz M., (1993) Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci. Lett. 156, 31-34. (Pubitemid 23214717)
35. Naidoo V., Naidoo S., Mahabeer R., and, Raidoo D. M., (2004) Cellular distribution of the endothelin system in the human brain. J. Chem. Neuroanat. 27, 87-98. (Pubitemid 38581104)
36. Narushima I., Kita T., Kubo K., Yonetani Y., Momochi C., Yoshikawa I., Ohno N., and, Nakashima T., (2003) Highly enhanced permeability of blood-brain barrier induced by repeated administration of endothelin-1 in dogs and rats. Pharmacol. Toxicol. 92, 21-26. (Pubitemid 36238073)
37. Pagotto U., Arzberger T., Hopfner U., Weindl A., and, Stalla G. K., (1995) Cellular localization of endothelin receptor mRNAs (ETA and ETB) in brain tumors and normal human brain. J. Cardiovasc. Pharmacol. 26 (Suppl. 3), S104-S106.
38. Palmer J., and, Love S., (2011) Endothelin receptor antagonists: potential in Alzheimer's disease. Pharmacol. Res. 63, 525-531.
39. Reijerkerk A., Kooij G., van der Pol S. M., Khazen S., Dijkstra C. D., and, de Vries H. E., (2006) Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J. 20, 2550-2552.
40. Reijerkerk A., Kooij G., van der Pol S. M., Leyen T., van het Hof B., Couraud P. O., Vivien D., Dijkstra C. D., and, de Vries H. E., (2008) Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier. J. Immunol. 181, 3567-3574.
41. Reijerkerk A., Kooij G., van der Pol S. M., Leyen T., Lakeman K., van het Hof B., Vivien D., and, de Vries H. E., (2010) The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier. J. Neurochem. 113, 447-453.
42. Rost B., and, Liu J., (2003) The PredictProtein server. Nucleic Acids Res. 31, 3300-3304. (Pubitemid 37442144)
43. Rubanyi G. M., and, Polokoff M. A., (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46, 325-415.
44. Schreibelt G., Kooij G., Reijerkerk A., et al. (2007) Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J. 21, 3666-3676. (Pubitemid 350075154)
45. Speciale L., Sarasella M., Ruzzante S., Caputo D., Mancuso R., Calvo M. G., Guerini F. R., and, Ferrante P., (2000) Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J. Neurovirol. 6 (Suppl. 2), S62-S66. (Pubitemid 30348914)
46. Suzuki H., Sato S., Suzuki Y., Takekoshi K., Ishihara N., and, Shimoda S., (1990) Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol. Scand. 81, 553-554. (Pubitemid 20220567)
47. Vos C. M., Geurts J. J., Montagne L., van Haastert E. S., Bo L., van der Valk P., Barkhof F., and, de Vries H. E., (2005) Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol. Dis. 20, 953-960. (Pubitemid 41619370)
48. de Vries H. E., Kuiper J., de Boer A. G., Van Berkel T. J., and, Breimer D. D., (1997) The blood-brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 49, 143-155. (Pubitemid 27291032)
49. Walters C. E., Pryce G., Hankey D. J., Sebti S. M., Hamilton A. D., Baker D., Greenwood J., and, Adamson P., (2002) Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis. J. Immunol. 168, 4087-4094. (Pubitemid 34298416)
50. Weksler B. B., Subileau E. A., Perriere N., et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19, 1872-1874. (Pubitemid 41598779)
51. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and, Masaki T., (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415. (Pubitemid 18090241)
52. Yoshimoto S., Ishizaki Y., Kurihara H., Sasaki T., Yoshizumi M., Yanagisawa M., Yazaki Y., Masaki T., Takakura K., and, Murota S., (1990) Cerebral microvessel endothelium is producing endothelin. Brain Res. 508, 283-285. (Pubitemid 20063461)
53. Zidovetzki R., Chen P., Chen M., and, Hofman F. M., (1999) Endothelin-1-induced interleukin-8 production in human brain-derived endothelial cells is mediated by the protein kinase C and protein tyrosine kinase pathways. Blood 94, 1291-1299. (Pubitemid 29380410)
54. Zlokovic B. V., (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201.